PT - JOURNAL ARTICLE AU - Jesús Ontañón AU - Joaquín Blas AU - Carlos de Cabo AU - Celia Santos AU - Elena Ruiz-Escribano AU - Antonio García AU - Luis Marín AU - Lourdes Sáez AU - José Luis Beato AU - Ramón Rada AU - Laura Navarro AU - Caridad Sainz de Baranda AU - Javier Solera TI - Influence of past infection with SARS-CoV-2 on the response to the BioTech/Pfizer BNT162b2 mRNA vaccine in health care workers: kinetics and durability of the humoral response AID - 10.1101/2021.05.25.21257788 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.25.21257788 4099 - http://medrxiv.org/content/early/2021/05/26/2021.05.25.21257788.short 4100 - http://medrxiv.org/content/early/2021/05/26/2021.05.25.21257788.full AB - Background Vaccines against SARS-CoV-2 have provided an invaluable resource in the fight against this infection. Given the current vaccine shortage, vaccination programs must prioritize their distribution to the most appropriate segments of the population.Methods We carried out a prospective cohort study with 63 health care workers (HCWs) from a public General Hospital. We compared antibody responses to two doses of BNT162b2 mRNA Covid-19 vaccine between HCWs with laboratory-confirmed SARS-CoV-2 infection before vaccination (experienced HCWs) and HCWs who were not previously infected (naïve HCWs).Results Seven days after the first vaccine dose HCWs with previous infection experienced a 126 fold increase in antibody levels (GMC 26955 AU; 95% CI 18785-35125). However, in the HCW naïve group the response was much lower and only 5 of them showed positive antibody levels (>50 AU). The HCWs with previous infection did not significantly increased their antibody levels after the second dose while there was a significant increase in the naive HCW group (16 fold; GMC 20227 AU; 95% CI: 15179-25275). Approximately two months after completing vaccination, the level of antibodies was much lower in naive HCWs (GMC 6595 AU vs. 25003 AU; p<0.001)Conclusion The study shows that 10 months after the disease has passed, the immune system is capable of producing a rapid and powerful secondary antibody response after one single dose of the vaccine. This response reflects the persistence of immunological memory and it is independent of whether or not anti-SARS-CoV-2 antibodies are detected in blood. Besides, we found that the second dose does not improve the antibody response in individuals with previous Covid-19 infection. Nonetheless, two months later, the persistence of antibody levels is still higher in the experienced HCWs. These data suggest that immune memory remains for a long time in recovered individuals, and therefore, vaccination in this group could be postponed until immunization of the rest of the population is complete.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialprospective cohort study 63 patients to test the effect of an existing vaccine in covid experienced and naive individuals. Does not qualify for clinicla trial.Funding StatementThis work did not receive any financial support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Comite de Etica de la Investigacion con medicamentos (CEIm) de la Gerencia de Atencion Integrada de Albacete (Albacete, Spain)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon request to the corresponding authors